Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0407-2026

Drug recall · March 25, 2026

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%* recall

Why: Lack of Assurance of Sterility

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1.

Lots / codes

Lots VJ8599, Exp Date 09/30/2026 & VL1668, Exp Date 01/31/2027

Quantity
107,136 vials
Company
Apotex Corp., Weston, FL
Distribution
U.S. Nationwide
Initiated
March 5, 2026 · Voluntary: Firm initiated
Classified
March 27, 2026
Reported
March 25, 2026
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Brimonidine / timolol

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.